Milburn Criticizes Shameful Spending Disparity on Youth Benefits vs Jobs South Koreas Deputy PM Warns AI Gains Must Be Shared Broadly Amid Samsung Labor Unrest Fanvue CEO Joel Morris Building a 200 Million Creator Economy Platform After Walking Away From Millions Entrata Files for US IPO Reports 23 Revenue Growth Backed by Silver Lake Lenovo Shares Surge Over 15 on Record Earnings as AI Revenue Nearly Doubles At Least 90 Killed in Chinese Coal Mine Explosion Worst Disaster in 17 Years PRDO Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Despite Opaque Revenue Picture SLGL Q4 2025 Earnings EPS Misses Estimates as DevelopmentStage Biotech Reports No Revenue FBYD Q1 2026 Earnings Narrowing Losses Amid Strategic Transformation FTAIM Q1 2026 Earnings EPS Falls Short of Estimates Preferred Shares Unchanged RRC Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency CLBT Q1 2026 Earnings EPS Surpasses Estimates by Nearly 19 Movado Group Inc MOV Rallies 345 as Retail Strength Emerges RedCloud Holdings RCT Shares Slide 6 as Stock Tests Key Support Level CBIZ Inc CBZ Rises 149 as Stock Tests Resistance Near 3352 SmartKem Inc SMTK Edges Higher in Thinly Traded Session Resistance at 025 Looms iShares Staked Ethereum Trust ETHB Edges Lower Amid Cautious Crypto Market Sentiment Dropbox CoFounder Andrew Houston to Step Down Insider Ashraf Alkarmi Named Successor Cass Information Systems Inc Q1 2026 Earnings Solid EPS Beat Amid Mixed Market Response TriNet Group TNET Edges Lower as Shares Test Key Support Levels Daily Journal Corp Q4 2025 Earnings Strong EPS of 3061 Reported Amid Flat Stock Reaction Diamond Hill Investment Group Inc DHIL Q1 2025 Earnings Reported EPS of 323 Amid Stable Market Conditions OFS Capital Corporation OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Net Investment Income Fox Corporation FOX Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction CZR Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Rises Despite Wider Loss Embecta Corp EMBC Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline